Homerespiratory

  • FDA Approves First Treatment for Group of Progressive Interstitial Lung Diseases

    • March 23, 2020
    • Posted by: PharmaScroll
    • Category:
    No Comments
    read more

  • AstraZeneca’s Fasenra Fails in Phase III COPD Trial

    • May 11, 2018
    • Posted by: PharmaScroll
    • Category:
    No Comments
    read more

  • Verona Pharma to Mark its Presence at BioEquity Europe 2018

    • May 5, 2018
    • Posted by: PharmaScroll
    • Category:
    No Comments
    read more

  • Vertex Initiates Phase 3 Studies of VX-445, Tezacaftor and Ivacaftor as a Triple Combination Regimen for People with Cystic Fibrosis

    • April 30, 2018
    • Posted by: PharmaScroll
    • Category:
    No Comments
    read more

  • GSK Appoints Senior Executive from Roche to Accelerate Pipeline Growth

    • April 20, 2018
    • Posted by: PharmaScroll
    • Category:
    No Comments
    read more

  • Trelegy Ellipta – IMPACT Study Shows Significant Benefits in COPD Patients

    • April 19, 2018
    • Posted by: PharmaScroll
    • Category:
    No Comments
    read more